Should You Sell Dr. Reddy’s Laboratories Ltd. ADR (RDY) And Go Away This Year?

Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) currently has a daily average trading volume of 1.06M but it saw 1327107 shares traded in last market. With a market cap of 13.05B USD, the company’s current market price of $15.67 came rising about 1.16 while comparing to the previous closing price of $15.49. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.89 and as low as $13.41. In the recent trading on the day, stock has struck highest price mark of $15.55 while lowest mark touched by it was $15.685.

Taking a look at 20-day trading activity of Dr. Reddy’s Laboratories Ltd. ADR (RDY) gives us an average price of $14.58, while its current price level is -7.23% below from 52-week high level whereas it is 16.85% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $14.83 while that of 200 days or SMA-200 reads an average of $15.12. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.48% during that period while stretching the period over a month that decreases to 1.28%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 70.06 which implies that the stock is in overbought territory.

Over the week, RDY’s stock price is moving 8.22% up while it is 10.35% when we observe its performance for the past one month. Year-to-date it is 12.60% up and over the past year, the stock is showing an upside performance of 16.37%.

Currently, Dr. Reddy’s Laboratories Ltd. ADR’s total number of outstanding shares is 834.38M. Company’s return on investment (ROI) stands at 17.14% and return on equity (ROE) at 19.12%. It has a price to earnings ratio (P/E ratio) of 20.43 while having a 19.27 of forward P/E ratio. Stock’s beta reads 0.52. Stock has a price to book (P/B) ratio of 3.59 while price to sale or P/S ratio amounts to 3.63. Its return on asset (ROA) is 13.14% on average.